Literature DB >> 23238814

Variable phenotypes of knockin mice carrying the M712T Gne mutation.

Ilan Sela1, Lena Yakovlev, Michal Becker Cohen, Moran Elbaz, Nurit Yanay, Uri Ben Shlomo, Hagit Yotvat, Yakov Fellig, Zohar Argov, Stella Mitrani-Rosenbaum.   

Abstract

GNE myopathy is a recessive adult onset, slowly progressive distal and proximal myopathy, caused by mutations in the GNE gene. The most frequent mutation in GNE myopathy patients is the Middle Eastern founder mutation M712T. We have generated Gne (M712T/M712T) knockin mice. A high mortality rate in the first generation due to renal failure was recorded (as previously described). However, the following Gne (M712T/M712T) offspring generations could be classified into 3 phenotypic categories: severe, mild and without apparent phenotype. By further crossing between mice with no apparent phenotype, we were able to establish a colony of Gne (M712T/M712T) knockin mice with a high- and long-term survival rate, lacking any renal phenotype. These mice did not present any muscle phenotype (clinical or pathological) for up to 18 months. No correlation was found between the expression of any of the two mRNA Gne isoforms in muscle and the mouse genotype or phenotype. However, the expression of isoform 2 mRNA was significantly higher in the kidney of Gne (M712T/M712T) kidney affected mice compared with control. In contrast, the expression of UPR markers Bip, Chop and of the spliced form of XBP1, was upregulated in muscle of Gne (M712T/M712T) mice compared with controls, but was unchanged in the affected kidney. Thus, Gne defects can affect both muscle and kidney in mouse, but probably through different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238814     DOI: 10.1007/s12017-012-8209-7

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  30 in total

1.  UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation.

Authors:  O T Keppler; S Hinderlich; J Langner; R Schwartz-Albiez; W Reutter; M Pawlita
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 2.  Siglecs--the major subfamily of I-type lectins.

Authors:  Ajit Varki; Takashi Angata
Journal:  Glycobiology       Date:  2005-07-13       Impact factor: 4.313

3.  The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy.

Authors:  I Eisenberg; N Avidan; T Potikha; H Hochner; M Chen; T Olender; M Barash; M Shemesh; M Sadeh; G Grabov-Nardini; I Shmilevich; A Friedmann; G Karpati; W G Bradley; L Baumbach; D Lancet; E B Asher; J S Beckmann; Z Argov; S Mitrani-Rosenbaum
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.

Authors:  May Christine V Malicdan; Satoru Noguchi; Ichizo Nishino
Journal:  Autophagy       Date:  2007-07-12       Impact factor: 16.016

5.  NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations.

Authors:  E Ricci; A Broccolini; T Gidaro; R Morosetti; C Gliubizzi; R Frusciante; G M Di Lella; P A Tonali; M Mirabella
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

6.  "Rimmed vacuole myopathy" sparing the quadriceps. A unique disorder in Iranian Jews.

Authors:  Z Argov; R Yarom
Journal:  J Neurol Sci       Date:  1984-04       Impact factor: 3.181

7.  A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.

Authors:  May Christine V Malicdan; Satoru Noguchi; Ikuya Nonaka; Yukiko K Hayashi; Ichizo Nishino
Journal:  Hum Mol Genet       Date:  2007-08-18       Impact factor: 6.150

8.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine.

Authors:  Belinda Galeano; Riko Klootwijk; Irini Manoli; MaoSen Sun; Carla Ciccone; Daniel Darvish; Matthew F Starost; Patricia M Zerfas; Victoria J Hoffmann; Shelley Hoogstraten-Miller; Donna M Krasnewich; William A Gahl; Marjan Huizing
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

10.  Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice.

Authors:  Mitutoshi Ito; Kazushi Sugihara; Tomoya Asaka; Tadashi Toyama; Toru Yoshihara; Kengo Furuichi; Takashi Wada; Masahide Asano
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

View more
  12 in total

1.  Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.

Authors:  Anna Nogalska; Carla D'Agostino; W King Engel; Mafalda Cacciottolo; Shinichi Asada; Kazutoshi Mori; Valerie Askanas
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

2.  Generation and Characterization of a Skeletal Muscle Cell-Based Model Carrying One Single Gne Allele: Implications in Actin Dynamics.

Authors:  Shamulailatpam Shreedarshanee Devi; Rashmi Yadav; Fluencephila Mashangva; Priyanka Chaudhary; Shweta Sharma; Ranjana Arya
Journal:  Mol Neurobiol       Date:  2021-09-12       Impact factor: 5.590

Review 3.  GNE myopathy: current update and future therapy.

Authors:  Ichizo Nishino; Nuria Carrillo-Carrasco; Zohar Argov
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-07-07       Impact factor: 10.154

4.  GNE myopathy: a personal trip from bedside observation to therapeutic trials.

Authors:  Zohar Argov
Journal:  Acta Myol       Date:  2014-10

5.  Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model.

Authors:  Yiumo Michael Chan; Paul Lee; Steve Jungles; Gabrielle Morris; Jaclyn Cadaoas; Alison Skrinar; Michel Vellard; Emil Kakkis
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

Review 6.  CDG Therapies: From Bench to Bedside.

Authors:  Sandra Brasil; Carlota Pascoal; Rita Francisco; Dorinda Marques-da-Silva; Giuseppina Andreotti; Paula A Videira; Eva Morava; Jaak Jaeken; Vanessa Dos Reis Ferreira
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

Review 7.  GNE myopathy: from clinics and genetics to pathology and research strategies.

Authors:  Oksana Pogoryelova; José Andrés González Coraspe; Nikoletta Nikolenko; Hanns Lochmüller; Andreas Roos
Journal:  Orphanet J Rare Dis       Date:  2018-05-02       Impact factor: 4.123

8.  Upregulation of Hallmark Muscle Genes Protects GneM743T/M743T Mutated Knock-In Mice From Kidney and Muscle Phenotype.

Authors:  Hadar Benyamini; Yehuda Kling; Lena Yakovlev; Michal Becker Cohen; Yuval Nevo; Sharona Elgavish; Avi Harazi; Zohar Argov; Ilan Sela; Stella Mitrani-Rosenbaum
Journal:  J Neuromuscul Dis       Date:  2020

9.  Altered Actin Dynamics in Cell Migration of GNE Mutant Cells.

Authors:  Shamulailatpam Shreedarshanee Devi; Rashmi Yadav; Ranjana Arya
Journal:  Front Cell Dev Biol       Date:  2021-03-18

10.  Role of IGF-1R in ameliorating apoptosis of GNE deficient cells.

Authors:  Reema Singh; Priyanka Chaudhary; Ranjana Arya
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.